You are here: Industry Insights > GMP

News List

Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up contractpharma
July 30, 2021
Abzena, a provider of solutions for biologics and bioconjugates, and BioXpress Therapeutics, a developer of monoclonal antibody (mAb) biosimilar therapeutics, have partnered to support biosimilar development for third party customers.
Capsida Unveils Next-Generation Gene Therapy Manufacturing contractpharma
July 28, 2021
New 15,000 square foot facility in Thousand Oaks will enable end-to-end gene therapy manufacturing capability.
Archimica’s $1.4 Million Manufacturing Expansion americanpharmaceuticalreview
July 23, 2021
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
Vetter’s New Clinical Manufacturing Site Now Fully Integrated b3cnewswire
July 22, 2021
A growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners that provide strategic support and comprehensive resources for their development process of new, promising injectable drug products.
MediPharm Labs Receives Canadian GMP Pharmaceutical DEL contractpharma
July 16, 2021
License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.
Idifarma Launches Accelerated Pathway for Complex Drugs contractpharma
July 15, 2021
‘Simply to Clinic’ leverages expertise in oral standard and highly potent drugs to take projects from pre-formulation to clinical trials.
Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem(TM) into clinic prnasia
July 12, 2021
Amniotics AB (publ), a stem cell therapy company has raised SEK60 million through its recent listing on Nasdaq First North Growth Market.
Second Curaleaf GMP cannabis facility gains Spanish approval cphi-online
July 08, 2021
Medalchemy facility now fully licensed to import, cultivate, extract, manufacture and export medical cannabis flower and extracts
Strides announces completion of EU GMP inspection at Puducherry facility expresspharma
June 30, 2021
The company has now received the renewed GMP certificate thereby confirming the successful closure of the inspection.
Lonza Expands API Development, Mfg. Facility in China contractpharma
June 29, 2021
Lonza is investing CHF 20 million in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page